List of Excipients in API guaifenesin and pseudoephedrine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing guaifenesin and pseudoephedrine hydrochloride
Excipients in ANDA-approved (generic) drugs containing guaifenesin and pseudoephedrine hydrochloride
Detailed excipient profiles for guaifenesin and pseudoephedrine hydrochloride
Excipient focus: ALUMINUM OXIDE
guaifenesin and pseudoephedrine hydrochloride drug variants containing ALUMINUM OXIDE
guaifenesin and pseudoephedrine hydrochloride drug variants not containing ALUMINUM OXIDE
Excipient focus: CARBOMER 934
guaifenesin and pseudoephedrine hydrochloride drug variants containing CARBOMER 934
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | guaifenesin and pseudoephedrine hydrochloride | 54868-5849 |
| >Company | >Ingredient | >NDC |
guaifenesin and pseudoephedrine hydrochloride drug variants not containing CARBOMER 934
Excipient focus: CARBOMER HOMOPOLYMER TYPE
guaifenesin and pseudoephedrine hydrochloride drug variants containing CARBOMER HOMOPOLYMER TYPE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin and pseudoephedrine hydrochloride | 51316-970 |
| >Company | >Ingredient | >NDC |
guaifenesin and pseudoephedrine hydrochloride drug variants not containing CARBOMER HOMOPOLYMER TYPE
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
guaifenesin and pseudoephedrine hydrochloride drug variants containing CARBOMER HOMOPOLYMER TYPE B
guaifenesin and pseudoephedrine hydrochloride drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | guaifenesin and pseudoephedrine hydrochloride | 51316-970 |
| Physicians Total Care Inc | guaifenesin and pseudoephedrine hydrochloride | 54868-5849 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
guaifenesin and pseudoephedrine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
guaifenesin and pseudoephedrine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
guaifenesin and pseudoephedrine hydrochloride drug variants containing FD&C YELLOW NO. 6
guaifenesin and pseudoephedrine hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYPROMELLOSE
guaifenesin and pseudoephedrine hydrochloride drug variants containing HYPROMELLOSE
guaifenesin and pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
guaifenesin and pseudoephedrine hydrochloride drug variants containing MAGNESIUM STEARATE
guaifenesin and pseudoephedrine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
guaifenesin and pseudoephedrine hydrochloride drug variants containing SILICON DIOXIDE
guaifenesin and pseudoephedrine hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
guaifenesin and pseudoephedrine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Meijer Inc | guaifenesin and pseudoephedrine hydrochloride | 79481-0119 |
| >Company | >Ingredient | >NDC |
guaifenesin and pseudoephedrine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
guaifenesin and pseudoephedrine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
guaifenesin and pseudoephedrine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
